Trial Profile
A prospective trial to evaluate the efficacy and safety of bevacizumab-based chemotherapy in patients with brain metastases from non-small-cell lung cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 May 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Cisplatin; Gemcitabine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 03 May 2016 New trial record